Trianta Immunotherapies' Acquisition

Trianta Immunotherapies was acquired by MediGene on January 27, 2014.

Trianta Immunotherapies was founded in late 2013 to exploit the therapeutic and commercial potential of innovative T cell-focused therapies developed by the team of Prof. Dolores Schendel at the Helmh…

Articles about Trianta Immunotherapies' Acquisition: